Barclays raised the firm’s price target on DuPont to $85 from $81 and keeps an Equal Weight rating on the shares. The company’s break-up announcement creates renewed debate about the “right multiple” for the shares, the analyst tells investors in a research note. However, the CEO’s exit is viewed as abrupt and the 18-24 month process likely leaves the shares relatively range bound near-term, says the firm.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DD:
- DuPont and NXP Semiconductors upgraded: Wall Street’s top analyst calls
- DuPont upgraded to Overweight from Equal Weight at Wells Fargo
- DuPont upgraded to Outperform from at BMO after separation plans
- DuPont upgraded to Outperform from Market Perform at BMO Capital
- Morgan Stanley expects positive share price response to DuPont’s spin off news